Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander C Ford

Showing results (271-280 of 451) with videos related to

Pageof 46
Sort By:
Alimentary Pharmacology & Therapeutics|October 28, 2024
Validating Simple Modifications to the Rome IV Criteria for the Diagnosis of Irritable Bowel Syndrome in Secondary CareVivek C Goodoory, Christy Riggott, Mais Khasawneh, et al.
Alimentary Pharmacology & Therapeutics|August 28, 2020
Systematic review with meta-analysis: global prevalence of uninvestigated dyspepsia according to the Rome criteriaBrigida Barberio, Sanjiv Mahadeva, Christopher J Black, et al.
The Lancet. Gastroenterology & Hepatology|July 2, 2026
The Rome V criteria for the diagnosis of irritable bowel syndrome in secondary care: a diagnostic accuracy studyKyle Staller, Vivek C Goodory, Mais Khasawneh, et al.
The Lancet. Gastroenterology & Hepatology|March 15, 2021
Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysisBrigida Barberio, Mohammad Zamani, Christopher J Black, et al.
American Journal of Epidemiology|August 4, 2005
Ethnicity, gender, and socioeconomic status as risk factors for esophagitis and Barrett's esophagusAlexander C Ford, David Forman, P Dominic Reynolds, et al.
Journal of Crohn'S & Colitis|June 21, 2011
Adalimumab as second line anti-tumour necrosis factor alpha therapy for Crohn's disease: A single centre experienceMichael B Sprakes, P John Hamlin, Lisa Warren, et al.
Therapeutic Advances in Gastroenterology|July 7, 2018
High prevalence of irritable bowel syndrome-type symptoms in microscopic colitis: implications for treatmentJohn S Kane, Andrew J Irvine, Yannick Derwa, et al.
World Journal of Gastroenterology|December 26, 2008
Adverse events with bismuth salts for Helicobacter pylori eradication: systematic review and meta-analysisAlexander C Ford, Peter Malfertheiner, Monique Giguere, et al.
The Lancet. Gastroenterology & Hepatology|October 12, 2025
Efficacy of behavioural therapies for irritable bowel syndrome: a systematic review and network meta-analysisElyse R Thakur, Mais Khasawneh, Paul Moayyedi, et al.
Lancet (London, England)|March 21, 2021
Satiation or satiety? More than mere semantics - Authors' replyM Florencia Carbone, Sanjiv Mahadeva, Brian E Lacy, et al.
Pageof 46

Showing results (271-280 of 451) with videos related to

Sort By:
Pageof 46
Alimentary Pharmacology & Therapeutics|October 28, 2024
Validating Simple Modifications to the Rome IV Criteria for the Diagnosis of Irritable Bowel Syndrome in Secondary CareVivek C Goodoory, Christy Riggott, Mais Khasawneh, et al.
Alimentary Pharmacology & Therapeutics|August 28, 2020
Systematic review with meta-analysis: global prevalence of uninvestigated dyspepsia according to the Rome criteriaBrigida Barberio, Sanjiv Mahadeva, Christopher J Black, et al.
The Lancet. Gastroenterology & Hepatology|July 2, 2026
The Rome V criteria for the diagnosis of irritable bowel syndrome in secondary care: a diagnostic accuracy studyKyle Staller, Vivek C Goodory, Mais Khasawneh, et al.
The Lancet. Gastroenterology & Hepatology|March 15, 2021
Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysisBrigida Barberio, Mohammad Zamani, Christopher J Black, et al.
American Journal of Epidemiology|August 4, 2005
Ethnicity, gender, and socioeconomic status as risk factors for esophagitis and Barrett's esophagusAlexander C Ford, David Forman, P Dominic Reynolds, et al.
Journal of Crohn'S & Colitis|June 21, 2011
Adalimumab as second line anti-tumour necrosis factor alpha therapy for Crohn's disease: A single centre experienceMichael B Sprakes, P John Hamlin, Lisa Warren, et al.
Therapeutic Advances in Gastroenterology|July 7, 2018
High prevalence of irritable bowel syndrome-type symptoms in microscopic colitis: implications for treatmentJohn S Kane, Andrew J Irvine, Yannick Derwa, et al.
World Journal of Gastroenterology|December 26, 2008
Adverse events with bismuth salts for Helicobacter pylori eradication: systematic review and meta-analysisAlexander C Ford, Peter Malfertheiner, Monique Giguere, et al.
The Lancet. Gastroenterology & Hepatology|October 12, 2025
Efficacy of behavioural therapies for irritable bowel syndrome: a systematic review and network meta-analysisElyse R Thakur, Mais Khasawneh, Paul Moayyedi, et al.
Lancet (London, England)|March 21, 2021
Satiation or satiety? More than mere semantics - Authors' replyM Florencia Carbone, Sanjiv Mahadeva, Brian E Lacy, et al.
Pageof 46